Table:
begin	end	state
1	26	cytoplasmic
27	50	transmembrane
51	55	non-cytoplasmic
56	76	transmembrane
77	103	cytoplasmic
104	128	transmembrane
129	134	non-cytoplasmic
135	156	transmembrane
157	165	cytoplasmic
166	186	transmembrane
187	206	non-cytoplasmic
207	231	transmembrane
232	251	cytoplasmic
252	271	transmembrane
272	290	non-cytoplasmic
291	313	transmembrane
314	338	cytoplasmic
339	360	transmembrane
361	366	non-cytoplasmic
367	391	transmembrane
392	404	cytoplasmic
405	427	transmembrane
428	432	non-cytoplasmic
433	452	transmembrane
453	466	cytoplasmic

Input:
>BPHYT_RS07280
MTQEQRGFDTIVEREKGLQRGLSTGQLSMIAIGGAIGTGLFLGSGFAIGFAGPSVLVSYA
IGALIALLLMGCLAEMTVAHPTSGSFGAYAEHYIAPWAGFLVRYAYWSSIVFAVGTEVTA
IAVYMKYWFPAVPGWYWIVGFSAALIGINSVSVKVFGAVEYVFSMLKIVAIVGFILLGAY
VVFGAPADSTIGFANYTSHGGFFPKGVWGMWVAVIVSIFSYLSIEMIAVAAGEARDPQKA
ITRAFRATMFRLVFFYLLTLALMLAIVPWNAAGTDESPFVRVMAATHVPGAAGVINFVIL
VAALSAMNSQLYITTRMMFSLSRAGYAPRKLGALNGKGVPVAALWLSTIGIALATVLNVV
YPDASFVLMMSVSMFGAMFTWLMIFVTHFFFRHRHQGAPLAFRMWGYPGTSALGAGLMVS
ALVTTWFTREFRMTLVIGVPFIVSLLVVYFVWYRKRAVEGAAAELA

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server